Liver Center Annual Symposium

Liver Center Annual Symposium

 Liver Center Annual Symposium 2022

April 29, 2022
8:30 AM - 12:00 PM
Parnassus Lecture Hall N225 (in person)

REGISTER NOW
 

8:30 – 8:45 Introduction

Jackie Maher, Liver Center Director

8:45 – 9:30 Keynote

Nicholas Davidson (Washington University): NASH-associated HCC: Novel insights from genetic models of impaired VLDL secretion

9:30 – 9:45 Break

9:45 – 10:25 Liver Metabolism & Organ Cross-Talk moderated by Marisa Medina (Pediatrics)

9:45 – 10:05 Emily Goldberg (Physiology; P&F grant awardee): Mechanisms of impaired ketogenesis during aging

10:05 – 10:15 Emad Heidaryarash (Willenbring Group, Surgery): Mechanistic insights into regulation of APOB secretion by TM6SF2

10:15 – 10:25 Stephanie Maldonado (Sarkar Group, Medicine): Polycystic ovary syndrome increases risk of non-alcoholic steatohepatitis: a US population-based study

10:25 – 11:05 Liver Injury & Immunology moderated by Amar Nijagal (Surgery)

10:25 – 10:45 Giuseppe Cullaro (Medicine; P&F grant awardee): Investigation of novel biomarkers of chronic kidney disease in cirrhosis patients

10:45 – 10:55 Claire O’Leary (Lockley Group, Medicine): Biliary immunity is regulated by tuft cells and the microbiome

10:55 – 11:05 Carson Cable (Chen Group, Medicine): Development of novel acid ceramidase inhibitors for the treatment of fibrotic diseases

11:05 – 11:15 Break

11:15 – 11:55 Liver Regeneration & Clinical Transplantation moderated by Chris Lau (Medicine)

11:15 – 11:35 Michael Bokoch (Anesthesia; P&F grant awardee): Angiotensin II in liver transplantation: a pilot randomized controlled trial

11:35 – 11:45 Aris Tay (Wang Group, Medicine): Sex differences in liver regeneration

11:45 – 11:55 Josh Norman (Mehta Group, Medicine): AFP-L3 and DCP biomarkers predict early post-liver transplant HCC recurrence

11:55 – 12:00 Conclusion

Holger Willenbring, Liver Center Associate Director